Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.00135-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Sarah Razzaq und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Chagas Disease, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Trypanocidal Agents. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council UK.
Abstract (Originalsprache)
Cardiomyopathy is the most common pathology associated with Trypanosoma cruzi infection. Reports that statins have both cardioprotective and trypanocidal activity have generated interest in their potential as a therapeutic treatment. Using a highly sensitive bioluminescent mouse model, we show that a 5-day treatment with statins has no significant impact on parasite load. The free systemic concentrations fail to reach the level required for potency. Hence, clinical trials to investigate the trypanocidal activity of statins lack experimental justification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Department of Parasitology, Faculty of Sciences, University of Granada, Granada, Andalusia, Spain.
- Global Health, Biomedical Research, Novartis, Emeryville, California, USA.
ORCID-Profile: Sarah Razzaq, Francisco Olmo, Suresh B Lakshminarayana, Srinivasa P S Rao, John M Kelly, Francisco A F
Förderung
- Medical Research Council UK
Zitieren
APA
Razzaq, S., Olmo, F., Lakshminarayana, S. B., Ying-Bo, C., Jayawardhana, S., Rao, S. P. S., Kelly, J. M., & A F, F. (2025). Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00135-25
Vancouver
Razzaq S, Olmo F, Lakshminarayana SB, Ying-Bo C, Jayawardhana S, Rao SPS, et al. Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00135-25
BibTeX
@article{Razzaq2025,
author = {Razzaq, Sarah and Olmo, Francisco and Lakshminarayana, Suresh B and Ying-Bo, Chen and Jayawardhana, Shiromani and Rao, Srinivasa P S and Kelly, John M and A F, Francisco},
title = {Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.00135-25}
}
EUVIMED